INTRODUCTION
Cardiotoxic side effects related to chemotherapy limit dosing and impose cancer survivor to enhanced morbidity and mortality. [1] Current established guidelines for screening of chemotherapy-related cardiotoxicity are mainly based on a serial assessment of the left ventricular ejection fraction. [2] Cardiac tissue is damaged by variety of ways during cancer treatment. [3] The speculated mechanism of valvular regurgitation could be secondary to chemotherapy-induced reduced ejection fraction, but insufficient data favors this mechanism as the whole. Degenerative valvular regurgitation disproportionate to decrease in the left ventricular ejection fraction and valvular or myocardial damage should be considered in survivors of chemotherapy survivors. [4] 
CASE REPORT
Our case was a 48-year-old woman who underwent chemotherapy for treatment of invasive ductal carcinoma of the breast. She was under close observation of cardiologist approach mitral regurgitation, cardiac condition started to recovery. Mitral regurgitation improved much better than cardiac contraction during a year after that. Finally, mitral regurgitation severity decreased to mild degree and left ventricular end diastolic volume decreased to 80 ml. Two-dimensional (2D) and 3D echocardiography images before and after recovery are depicted in Figures 1 and 2 , respectively.
DISCUSSIONS
Hereby, we presented a case of severe mitral regurgitation during chemotherapy which improved significantly by cessation of chemotherapy, in addition to appropriate cardiac treatment. Severe mitral regurgitation is a yet unreported manifestation of chemotherapy-induced cardiotoxicity which needs prompt attention. Fortunately, mitral regurgitation was reversible similar to left ventricular dysfunction, and we did not need an interventional and invasive strategy to manage it. Since each chemotherapy agent has an impact on cardiovascular system, cardio-oncology knowledge should be joined from the beginning of patient management.
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